What is Bioventus's current ratio?

Bioventus (BVS) reported current ratio of 1.7× in Q1 2026.

How has Bioventus's current ratio changed year-over-year?

Bioventus's current ratio increased by 18.2% year-over-year, from 1.4× to 1.7×.

What is the long-term trend for Bioventus's current ratio?

Over 5 years (2020 to 2025), Bioventus's current ratio has grown at a -0.3% compound annual growth rate (CAGR), from 1.7× to 1.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Bioventus BVS Current ratio

Current ratio at other companies

StrykerSYK

2.1×+0.5×

Zimmer Biomet HoldingsZBH

1.7×-0.7×

MedtronicMDT

2.1×+0.3×

SI-BONE, Inc.SIBN

10×+1.5×

ArtivionAORT

3.9×-1.7×

Globus MedicalGMED

4.6×+0.1×

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Where this comes from

Calculated from Bioventus’s reported figures.

total current assets/total current liabilities=1.7×

Based on the most recent quarter.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's current ratio?: Bioventus (BVS) reported current ratio of 1.7× in Q1 2026.
How has Bioventus's current ratio changed year-over-year?: Bioventus's current ratio increased by 18.2% year-over-year, from 1.4× to 1.7×.
What is the long-term trend for Bioventus's current ratio?: Over 5 years (2020 to 2025), Bioventus's current ratio has grown at a -0.3% compound annual growth rate (CAGR), from 1.7× to 1.7×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.